March 17, 2026

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating the 35% Upside Potential

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands at the intersection of healthcare innovation and investment opportunity. As a prominent player in the medical devices industry, Tandem specializes in advanced insulin..

Evotec SE (EVO) Stock Analysis: Unlocking a Potential 115% Upside in Drug Discovery

Evotec SE (EVO), a prominent player in the healthcare sector, is making waves in the drug manufacturing industry with its focus on a wide array of therapeutic areas. Headquartered in..

Neogen Corporation (NEOG) Stock Analysis: Unpacking the 28% Potential Upside in the Healthcare Sector

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in medical devices, has recently caught the attention of investors with a notable potential upside of approximately 28.06%...

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring 37% Upside Potential in Bioelectric Medicine

Pulse Biosciences, Inc (NASDAQ: PLSE) is a compelling player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.48 billion, this Miami-based..

Celldex Therapeutics (CLDX) Investor Outlook: Exploring an 82% Potential Upside in the Biotech Arena

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to treating severe inflammatory and autoimmune diseases. Based..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Promising 36.97% Upside in the Biotech Sector

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is capturing the attention of investors with a compelling potential upside of 36.97%, making it a noteworthy consideration in the biotechnology sector. With a current..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 60% Potential Upside

For investors keen on the healthcare sector, Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) presents an intriguing opportunity. As a key player in the medical care facilities industry, Aveanna is making..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a Potential 79.76% Upside for This Healthcare Challenger

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the diagnostics and research industry, is making waves in the investment community with its recent market performance. With a market capitalization of..

Apellis Pharmaceuticals, Inc. (APLS) Investor Outlook: Exploring a 78% Potential Upside

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a key player in the biotechnology sector, offers intriguing opportunities for investors seeking exposure to innovative healthcare solutions. With a market capitalization of $2.41 billion,..

Haemonetics Corporation (HAE) Stock Report: Exploring a 46.57% Potential Upside Amidst a Challenging Year

Haemonetics Corporation (NYSE: HAE), a leading player in the healthcare sector specializing in medical devices, presents an intriguing yet complex investment opportunity. Based in Boston, Massachusetts, the company is renowned..

Alphatec Holdings (ATEC) Stock Analysis: Exploring a 92.92% Potential Upside in the Medical Devices Sector

Alphatec Holdings, Inc. (NYSE: ATEC), a key player in the medical devices industry, has captured the attention of investors with a remarkable potential upside of 92.92%. Specializing in innovative spinal..

MiMedx Group, Inc (MDXG) Stock Analysis: Biotechnology Innovator with 119.20% Potential Upside

Investors seeking opportunities in the healthcare sector may want to turn their attention to MiMedx Group, Inc (MDXG), a promising player in the biotechnology industry. With a market capitalization of..

Denali Therapeutics (DNLI) Stock Analysis: Assessing a 60% Upside Potential in Neurodegenerative Therapies

Denali Therapeutics Inc. (NASDAQ: DNLI) is making waves in the biotechnology sector with its innovative approach to tackling neurodegenerative and lysosomal storage diseases. With a market capitalization of $3.26 billion,..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Unveiling a Potential 289% Upside in the Biotech Sector

Investors with a keen interest in the biotechnology sector may find Janux Therapeutics, Inc. (NASDAQ: JANX) an intriguing prospect, thanks to its promising pipeline and potential upside. With a market..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 19% Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG), a prominent player in the medical care facilities sector, presents a compelling opportunity for investors seeking exposure within the healthcare industry. With a market..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential 74.9% Upside for Savvy Investors

Perrigo Company plc (NYSE: PRGO) presents an intriguing opportunity for investors seeking to capitalize on potential upside in the healthcare sector. Known for its robust portfolio of over-the-counter health and..

BioLife Solutions, Inc. (BLFS) Investor Outlook: Aiming for 69.81% Upside Potential

BioLife Solutions, Inc. (NASDAQ: BLFS), a notable player in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with its impressive growth metrics and the potential..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Healthcare Giant with 36.64% Upside Potential

Brookdale Senior Living Inc. (NYSE: BKD), a major player in the healthcare sector, operates within the medical care facilities industry and focuses on the senior living community market in the..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: A 51% Potential Upside Awaits Investors

Investors seeking opportunities in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, should not overlook Indivior Pharmaceuticals, Inc. (NASDAQ: INDV). With a market capitalization of $3.87..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Promising 52.68% Upside Potential Awaits Investors

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a promising player in the biotechnology sector focusing on dermatological treatments, presents a compelling case for investors seeking growth opportunities. With an impressive market capitalization..

Search

Funds

March 17, 2026

Search

Funds

March 17, 2026

FTSE 100

Funds